All eyes on EU regulator as AstraZeneca decision to be released

ads

All eyes on EU regulator as AstraZeneca decision to be released

The European Medicines Agency (EMA) is due to provide an assessment on Thursday of the safety of Astrazeneca’s vaccine against Covid-19 after several countries temporarily suspended use of the jab over fears about side effects.

The EMA’s safety committee has been making a detailed evaluation of a small number of cases concerning blood clots occurring in recipients of the vaccine.

See also  Okowa to hold private burial for late father, appreciates Nigerians

The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is to issue any necessary recommendations for further action after its meeting on Thursday.

Following reports of the blood clot cases, some countries in the European Union suspended use of the vaccine, further delaying already sluggish inoculation campaigns.

Many said they were waiting for guidance from the EMA.

See also  Why 2021 Tech Expo ‘ll not be like trade fair – Onu

The EMA said it was looking at available data related to all thromboembolic events reported after vaccination, including additional data provided by national health agencies.

“Rapid and thorough analysis of the available data and clinical circumstances surrounding specific cases is continuing, to determine whether the vaccine might have contributed or if events are likely to have been due to other causes,” the EMA said.

See also  Insecurity: Some governors not serious with their jobs, says Yahaya Bello

Both the EMA and the World Health Organization (WHO) recommended continuing inoculation with AstraZeneca’s vaccine until further notice, noting its benefits outweighed the risks of Covid-19.

Vanguard News Nigeria

The post All eyes on EU regulator as AstraZeneca decision to be released appeared first on Vanguard News.

ads

Be the first to comment

Leave a Reply